PortfoliosLab logoPortfoliosLab logo
BLZE vs. GH
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

BLZE vs. GH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Backblaze, Inc. (BLZE) and Guardant Health, Inc. (GH). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

BLZE vs. GH - Yearly Performance Comparison


2026 (YTD)20252024202320222021
BLZE
Backblaze, Inc.
-23.39%-22.59%-20.69%23.41%-63.59%-15.13%
GH
Guardant Health, Inc.
-10.76%234.34%12.94%-0.55%-72.81%-5.00%

Fundamentals

Market Cap

BLZE:

$200.67M

GH:

$11.73B

EPS

BLZE:

-$0.46

GH:

-$3.30

PS Ratio

BLZE:

1.38

GH:

11.70

Total Revenue (TTM)

BLZE:

$145.84M

GH:

$982.02M

Gross Profit (TTM)

BLZE:

$88.79M

GH:

$633.01M

EBITDA (TTM)

BLZE:

-$2.83M

GH:

-$375.72M

Returns By Period

In the year-to-date period, BLZE achieves a -23.39% return, which is significantly lower than GH's -10.76% return.


BLZE

1D
3.48%
1M
-7.99%
YTD
-23.39%
6M
-60.86%
1Y
-27.59%
3Y*
-10.92%
5Y*
10Y*

GH

1D
-1.32%
1M
-1.17%
YTD
-10.76%
6M
45.49%
1Y
114.62%
3Y*
57.25%
5Y*
-10.30%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BLZE vs. GH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BLZE
BLZE Risk / Return Rank: 2626
Overall Rank
BLZE Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
BLZE Sortino Ratio Rank: 2525
Sortino Ratio Rank
BLZE Omega Ratio Rank: 2525
Omega Ratio Rank
BLZE Calmar Ratio Rank: 2929
Calmar Ratio Rank
BLZE Martin Ratio Rank: 3030
Martin Ratio Rank

GH
GH Risk / Return Rank: 8989
Overall Rank
GH Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
GH Sortino Ratio Rank: 9090
Sortino Ratio Rank
GH Omega Ratio Rank: 8686
Omega Ratio Rank
GH Calmar Ratio Rank: 9090
Calmar Ratio Rank
GH Martin Ratio Rank: 8888
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BLZE vs. GH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Backblaze, Inc. (BLZE) and Guardant Health, Inc. (GH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BLZEGHDifference

Sharpe ratio

Return per unit of total volatility

-0.41

2.01

-2.42

Sortino ratio

Return per unit of downside risk

-0.16

2.87

-3.04

Omega ratio

Gain probability vs. loss probability

0.98

1.35

-0.37

Calmar ratio

Return relative to maximum drawdown

-0.38

3.97

-4.34

Martin ratio

Return relative to average drawdown

-0.69

9.81

-10.50

BLZE vs. GH - Sharpe Ratio Comparison

The current BLZE Sharpe Ratio is -0.41, which is lower than the GH Sharpe Ratio of 2.01. The chart below compares the historical Sharpe Ratios of BLZE and GH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


BLZEGHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.41

2.01

-2.42

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.15

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.42

0.22

-0.64

Correlation

The correlation between BLZE and GH is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

BLZE vs. GH - Dividend Comparison

Neither BLZE nor GH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BLZE vs. GH - Drawdown Comparison

The maximum BLZE drawdown since its inception was -89.49%, roughly equal to the maximum GH drawdown of -91.03%. Use the drawdown chart below to compare losses from any high point for BLZE and GH.


Loading graphics...

Drawdown Indicators


BLZEGHDifference

Max Drawdown

Largest peak-to-trough decline

-89.49%

-91.03%

+1.54%

Max Drawdown (1Y)

Largest decline over 1 year

-69.21%

-28.73%

-40.48%

Max Drawdown (5Y)

Largest decline over 5 years

-90.30%

Current Drawdown

Current decline from peak

-88.67%

-49.11%

-39.56%

Average Drawdown

Average peak-to-trough decline

-77.41%

-51.83%

-25.58%

Ulcer Index

Depth and duration of drawdowns from previous peaks

37.71%

11.62%

+26.09%

Volatility

BLZE vs. GH - Volatility Comparison

The current volatility for Backblaze, Inc. (BLZE) is 9.94%, while Guardant Health, Inc. (GH) has a volatility of 12.83%. This indicates that BLZE experiences smaller price fluctuations and is considered to be less risky than GH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


BLZEGHDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.94%

12.83%

-2.89%

Volatility (6M)

Calculated over the trailing 6-month period

55.59%

40.46%

+15.13%

Volatility (1Y)

Calculated over the trailing 1-year period

68.23%

57.26%

+10.97%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

77.47%

67.04%

+10.43%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.47%

68.16%

+9.31%

Financials

BLZE vs. GH - Financials Comparison

This section allows you to compare key financial metrics between Backblaze, Inc. and Guardant Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
37.76M
281.27M
(BLZE) Total Revenue
(GH) Total Revenue
Values in USD except per share items

BLZE vs. GH - Profitability Comparison

The chart below illustrates the profitability comparison between Backblaze, Inc. and Guardant Health, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%55.0%60.0%65.0%70.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
62.0%
64.6%
Portfolio components
BLZE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Backblaze, Inc. reported a gross profit of 23.43M and revenue of 37.76M. Therefore, the gross margin over that period was 62.0%.

GH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Guardant Health, Inc. reported a gross profit of 181.77M and revenue of 281.27M. Therefore, the gross margin over that period was 64.6%.

BLZE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Backblaze, Inc. reported an operating income of -4.67M and revenue of 37.76M, resulting in an operating margin of -12.4%.

GH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Guardant Health, Inc. reported an operating income of -120.81M and revenue of 281.27M, resulting in an operating margin of -43.0%.

BLZE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Backblaze, Inc. reported a net income of -5.41M and revenue of 37.76M, resulting in a net margin of -14.3%.

GH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Guardant Health, Inc. reported a net income of -128.49M and revenue of 281.27M, resulting in a net margin of -45.7%.